W Fuchs1, U Wieland2, A Skaletz-Rorowski3, N H Brockmeyer1, J Swoboda4, A Kreuter1, C Michalik3,5, A Potthoff1. 1. Department of Dermatology, Venereology and Allergology, Center for Sexual Health and Medicine, Ruhr-University Bochum, Bochum, Germany. 2. National Reference Center for Papilloma- and Polyomaviruses, Institute of Virology, Uniklinik Köln, University of Cologne, Koeln, Germany. 3. Competence Network for HIV/AIDS (KompNet HIV/AIDS), Ruhr-University Bochum, Bochum, Germany. 4. Institute of Cytology, Bonn, Germany. 5. Clinical Trial Centre (ZKS), University of Cologne, Cologne, Germany.
Abstract
BACKGROUND: Human papillomaviruses (HPV) induce condylomata, anogenital cancers and their precursor lesions as anal or penile intraepithelial neoplasia (AIN/PIN). HIV-positive individuals have an increased risk for the development of anogenital HPV-induced lesions. OBJECTIVE: Estimation of the prevalence of HPV-related anogenital benign and malignant lesions in HIV-infected men attending a screening programme. METHODS: Four hundred HIV-positive men [98% men who have sex with men (MSM)] were enrolled in this prospective study from 2008 to 2011. All patients received an inspection of the anogenital region, digital rectal examination, high-resolution anoscopy (HRA), anal cytology, anal/penile histology if required, and HPV-typing of anal and penile swabs. RESULTS: At baseline, 75% (n = 302) of the men had abnormal anal cytological/histological results. 41% presented with low-grade (n = 164), 24% with high-grade anal dysplasia (n = 95) and two men with invasive anal cancer. 2.3% had PIN (n = 9) and one patient had penile cancer at baseline. Throughout the study period, 75% had anal dysplasia (low-grade n = 177, high-grade n = 125), 3.3% (n = 13) had PIN and two further patients developed anal cancer. Within the study period, 52.8% (n = 211) had condylomata (49% anal, 15% penile, 11% anal plus penile condylomata). At baseline, 88.5% of anal and 39.3% of penile swabs were HPV-DNA positive, and 77.8% of anal and 26.5% of penile swabs carried high-risk HPV-types. HPV16 was the most frequent HPV-type. CONCLUSION: HIV-positive MSM have a high risk for HPV-induced condylomata, (pre)malignant anogenital lesions and anogenital cancers. Screening for HPV-induced dysplasia is crucial to avoid progression to invasive carcinomas. Additionally, HPV-vaccination recommendations should be extended to high-risk populations.
BACKGROUND:Human papillomaviruses (HPV) induce condylomata, anogenital cancers and their precursor lesions as anal or penile intraepithelial neoplasia (AIN/PIN). HIV-positive individuals have an increased risk for the development of anogenital HPV-induced lesions. OBJECTIVE: Estimation of the prevalence of HPV-related anogenital benign and malignant lesions in HIV-infectedmen attending a screening programme. METHODS: Four hundred HIV-positive men [98% men who have sex with men (MSM)] were enrolled in this prospective study from 2008 to 2011. All patients received an inspection of the anogenital region, digital rectal examination, high-resolution anoscopy (HRA), anal cytology, anal/penile histology if required, and HPV-typing of anal and penile swabs. RESULTS: At baseline, 75% (n = 302) of the men had abnormal anal cytological/histological results. 41% presented with low-grade (n = 164), 24% with high-grade anal dysplasia (n = 95) and two men with invasive anal cancer. 2.3% had PIN (n = 9) and one patient had penile cancer at baseline. Throughout the study period, 75% had anal dysplasia (low-grade n = 177, high-grade n = 125), 3.3% (n = 13) had PIN and two further patients developed anal cancer. Within the study period, 52.8% (n = 211) had condylomata (49% anal, 15% penile, 11% anal plus penile condylomata). At baseline, 88.5% of anal and 39.3% of penile swabs were HPV-DNA positive, and 77.8% of anal and 26.5% of penile swabs carried high-risk HPV-types. HPV16 was the most frequent HPV-type. CONCLUSION: HIV-positive MSM have a high risk for HPV-induced condylomata, (pre)malignant anogenital lesions and anogenital cancers. Screening for HPV-induced dysplasia is crucial to avoid progression to invasive carcinomas. Additionally, HPV-vaccination recommendations should be extended to high-risk populations.
Authors: Hector Posso; Leith León-Maldonado; Betania Allen-Leigh; Jorge Salmerón; Manuel Quiterio; Anna R Giuliano; Staci L Sudenga; Alan G Nyitray; B Nelson Torres; Martha Abrahamsen; Eduardo Lazcano-Ponce Journal: Salud Publica Mex Date: 2018 Nov-Dec
Authors: G A Binda; G Gagliardi; I Dal Conte; M Verra; P Cassoni; E Cavazzoni; E Stocco; S Delmonte; P De Nardi; L Sticchi; M Mistrangelo Journal: Tech Coloproctol Date: 2019-06-26 Impact factor: 3.781
Authors: Danielle R L Brogden; Christopher C Khoo; Christos Kontovounisios; Gianluca Pellino; Irene Chong; Diana Tait; Oliver J Warren; Mark Bower; Paris Tekkis; Sarah C Mills Journal: Discov Oncol Date: 2021-02-11
Authors: Amelia B Thompson; Scott E Gillespie; Marina B Mosunjac; Sophia A Hussen; Lisa C Flowers; Andres F Camacho-Gonzalez Journal: J Low Genit Tract Dis Date: 2018-10 Impact factor: 1.925
Authors: Thomas Weiland; Alexander Eckert; Peter Valentin Tomazic; Axel Wolf; Prisca Pondorfer; Sarah Vasicek; Matthias Graupp; Clemens Holzmeister; Ulrich Moser; Alexandros Andrianakis; Georg Kangler; Peter Kiss; Luka Brcic; Matthias Kappler; Claudia Wickenhauser; Anja Haak; Maximilian Krüger; Bilal Al-Nawas; Sebastian Blatt; Norbert Brockmeyer; Adriane Skaletz-Rorowski; Anja Potthoff; Lars E French; Sara Charnowski; Markus Reinholz; Andreas M Kaufmann; Sarah Thies; Hans-Georg Lambrecht; Barbara Seliger; Dominik C Wild; Dietmar Thurnher Journal: EBioMedicine Date: 2020-06-11 Impact factor: 8.143
Authors: Danielle R L Brogden; Una Walsh; Gianluca Pellino; Christos Kontovounisios; Paris Tekkis; Sarah C Mills Journal: Int J Colorectal Dis Date: 2020-09-26 Impact factor: 2.796